肺部芽细胞瘤后的死性肺炎:一个病例报告
Kyle A Burton1, Matthew Karulf2
1Internal Medicine, Michigan State University College of Human Medicine, Marquette, USA.
Cureus
|June 12, 2023
概括
肺结核性肺炎是肺芽细胞菌的严重并发症,在本案例研究中详细介绍. 它突出了一个患有Blastomyces dermatitidis感染的患者,导致肺组织死亡.
科学领域:
- 菌类学 菌类学是指菌类学.
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 肺部骨髓炎是一种由Blastomyces dermatitidis子引起的真菌感染.
- 死亡性肺炎是这种感染的罕见,严重并发症.
相关概念视频
Pulmonary Tuberculosis II
281
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
281
Pneumonia II: Pathophysiology
365
The pathophysiology of pneumonia involves the following steps:
365
Pneumonia I: Introduction
285
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
285
Pneumonia III: Complications and Assessment
281
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
281
Pneumonia IV: Management
399
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
399
Pulmonary Tuberculosis III
382
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
382


